Sabtu, 24 September 2011

[D790.Ebook] Ebook Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press

Ebook Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press

Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press How a straightforward concept by reading can enhance you to be a successful individual? Reading Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press is a quite easy activity. Yet, exactly how can many people be so lazy to read? They will certainly like to invest their free time to talking or socializing. When in fact, checking out Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press will give you more probabilities to be effective completed with the efforts.

Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press

Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press



Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press

Ebook Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press

Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press. Reading makes you better. Which claims? Many wise words say that by reading, your life will certainly be a lot better. Do you believe it? Yeah, prove it. If you need the book Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press to review to prove the smart words, you can see this page perfectly. This is the site that will supply all the books that possibly you require. Are the book's compilations that will make you really feel interested to read? One of them right here is the Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press that we will certainly recommend.

Keep your means to be below and also read this web page completed. You could enjoy searching the book Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press that you actually describe obtain. Right here, getting the soft file of the book Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press can be done quickly by downloading and install in the web link web page that we provide right here. Naturally, the Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press will be your own sooner. It's no have to wait for guide Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press to receive some days later after acquiring. It's no need to go outside under the heats at mid day to go to the book store.

This is a few of the advantages to take when being the participant as well as get guide Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press here. Still ask just what's various of the various other site? We give the hundreds titles that are developed by recommended writers and authors, all over the world. The connect to acquire and download Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press is also extremely easy. You could not locate the complex site that order to do even more. So, the way for you to get this Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press will be so simple, will not you?

Based upon the Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press specifics that we offer, you may not be so baffled to be here and to be member. Obtain now the soft file of this book Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press and also save it to be your own. You saving could lead you to evoke the simplicity of you in reading this book Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press Also this is forms of soft data. You could actually make better possibility to get this Spinal Muscular Atrophy: Disease Mechanisms And TherapyFrom Academic Press as the advised book to review.

Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press

Spinal Muscular Atrophy: Disease Mechanisms and Therapy provides the latest information on a condition that is characterized by motoneuron loss and muscle atrophy, and is the leading genetic cause of infant mortality. Since the identification of the gene responsible for SMA in 1995, there have been important advances in the basic understanding of disease mechanisms, and in therapeutic development.

This book provides a comprehensive accounting of recent advances in basic and clinical research that covers SMA clinical features and standards of care, multifaceted aspects of SMN protein functions and SMA disease pathology, various animal models, and biomarkers, as well as current therapeutic development.

This title is ideal for graduate students/postdocs and principal investigators who are already in the SMA field and need to keep updated on recent findings and approaches, and for those who are new to, or would like to join, the field. Likewise, users will find an excellent source of reading for biotech/pharma scientists, clinical researchers, and practitioners, regulators, and patients and their advocacy organizations. Furthermore, this book is a handy reference for researchers and clinicians who may want to apply the research strategies and therapeutic approaches in SMA to other rare diseases.

  • Provides comprehensive, up-to-date reviews by leading investigators on diverse topics of SMA, including clinical features and patient care, SMN genetics and protein functions, animal models, disease pathology and mechanisms, biomarkers, current therapeutic development, and the role of non-profit organizations in therapeutic development
  • Written to bridge multiple disciplines and promote better communications among basic scientists, clinical researchers, and health care providers on the latest developments in SMA
  • Includes outstanding questions and perspectives for future investigations and key references for additional detailed study

  • Sales Rank: #1188327 in Books
  • Published on: 2016-11-18
  • Original language: English
  • Dimensions: 11.00" h x 1.20" w x 8.70" l,
  • Binding: Hardcover
  • 506 pages

Review

This comprehensive, state-of-the-art textbook, covering all aspects of SMA, is very timely and should provide a springboard for further efforts and advances in the future. -- Victor Dubowitz, M.D., Ph.D., Emeritus Professor of Paediatrics, University of London, London, UK.

This book is written by experts who contribute to major progress in the fields of SMA from the clinical features, molecular mechanisms, animal models, therapeutic developments to clinical trials. I have no doubt that this book will become an indispensable resource for clinicians and scientists having the goal to cure SMA. -- Judith Melki, M.D., Ph.D., Professor of Medical Genetics, Medicine Faculty, University of Paris 11; Inserm and University of Paris 11, U-788, Kremlin-Bicetre Hospital, Paris, France.

Now there is an important book which chronicles the many paths and diverse approaches taken to understand SMA and develop therapies, a clear strength of the SMA field has been the extensive sharing of data that has advanced the field rapidly. --Arthur H.M. Burghes, Ph.D., Professor, Department of Biological Chemistry and Pharmacology, College of Medicine, The Ohio State University, Columbus, OH, USA.

We have come a long way on the path to therapeutics development for SMA, and safe and effective treatment is now within reach. This book comes at an opportune time to take stock of where we are on this path and to see what the future holds. -- Kenneth H. Fischbeck, M.D., NIH Distinguished Investigator, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

From the Back Cover

Spinal Muscular Atrophy (SMA), characterized by motoneuron loss and muscle atrophy, is the leading genetic cause of infant mortality. Since the identification of the gene responsible for SMA in 1995, there have been important advances in basic understanding of disease mechanisms as well as in therapeutic development. Spinal Muscular Atrophy: Disease Mechanisms and Therapy is a comprehensive reading of recent advances in basic and clinical research. The book covers SMA clinical features and standards of care, multifaceted aspects of SMN protein functions and SMA disease pathology, various animal models, biomarkers, as well as current therapeutic development for the disease.

This title is ideal for graduate students/postdocs and principal investigators who are already in the SMA field and need to keep updated of recent findings and approaches, and also those who are new to, or would like to join, the field. Likewise, Spinal Muscular Atrophy: Disease Mechanisms and Therapy provides an excellent source of readings for biotech/pharma scientists, clinical researchers and practitioners, regulators, as well as patients and their advocacy organizations. Furthermore, this book is a handy reference for researchers and clinicians who may want to apply the research strategies and therapeutic approaches in SMA to other rare diseases.

About the Author
Dr. Charlotte J. Sumner is an Associate Professor of Neurology and Neuroscience at Johns Hopkins University School of Medicine. She received her B.A. from Princeton University and her M.D. from the University of Pennsylvania School of Medicine. She completed internal medicine internship and neurology residency at the University of California San Francisco and neuromuscular fellowship at Johns Hopkins University School of Medicine. Her scientific training included Neurogenetics fellowship at the National Institute of Neurological Disorders and Stroke. Dr. Sumner cares for patients with inherited diseases of motor neurons and peripheral nerves such as spinal muscular atrophy (SMA) and Charcot-Marie-Tooth (CMT) disease and co-directs the Johns Hopkins CMT clinic. Dr. Sumner’s research focuses on the genetic and cellular pathogenesis of SMAs with particular attention to therapeutics development for these disorders utilizing cell and mouse models and human tissues. This work has included identification of novel genetic causes of these disorders, characterization of molecular and cellular mechanisms underlying disease pathogenesis, and preclinical development of therapeutics now advancing to clinical trials in SMA patients. Dr. Sumner’s laboratory research has been funded by the National Institute of Neurological Disorders and Stroke, Muscular Dystrophy Association, Cure SMA, the Spinal Muscular Atrophy Foundation, Spinal Muscular Atrophy Research Team, Ujala Foundation, and the Howard Hughes Medical Institute. She is an Associate Editor of the journal Experimental Neurology and advisor to several companies developing treatments for SMA as well as nonprofit foundations including the Packard Center for ALS research, ALS Association, Cure SMA, and the SMA Foundation.

Dr. Sergey Paushkin is Director of Research at the Spinal Muscular Atrophy (SMA) Foundation. He is responsible for coordinating research efforts of pharmaceutical, biotech, academic, and contract research organizations with the goal of bringing therapeutics to patients with SMA. Dr. Paushkin has more than 20 years of experience in biomedical research related to rare diseases and has been working in the SMA field since 1998. His work on SMA started during postdoctoral training at the Howard Hughes Medical Institute (University of Pennsylvania), where he studied molecular mechanisms of the disease, including the organization and function of the SMN complex. Dr. Paushkin continued working on SMA at PTC Therapeutics, where he established the SMA program and led drug discovery efforts, prior to moving to the SMA Foundation. Dr. Paushkin’s expertise in SMA extends from molecular mechanisms of disease pathogenesis to drug discovery and development of therapeutics. Dr. Paushkin’s work is focused on implementing strategies to overcome translational barriers in preclinical and clinical research by establishing and leading collaborations between industry, academic institutions and CROs, as well as developing strong relationship with the SMA community.

Dr. Paushkin received his MD from the Russian State Medical University and PhD in Biochemistry from the Cardiology Research Center, Moscow. His undergraduate research was focused on the molecular basis of prion diseases, including prion protein conversion.

Dr. Chien-Ping Ko is a Professor of Neurobiology at University of Southern California Dornsife College of Letters, Arts and Sciences. Dr. Ko received his B.S. from National Taiwan University in Taipei, Taiwan, and Ph.D. from Washington University in St. Louis. Dr. Ko completed his postdoctoral training at University of Colorado Medical Center in Denver, and at the National Institute of Neurological Disorders and Stroke, NIH, in Bethesda. He served on the editorial board of the Journal of Neurocytology and Neuron Glia Biology and edited a special issue on the Neuromuscular Junction (NMJ) for the Journal of Neurocytology in 2003. Dr. Ko received an NIH Research Career Development Award and grants including past/current supports from NIH, NSF, Muscular Dystrophy Association, the ALS Association, Cure SMA, the Dhont Family Foundation, and the SMA Foundation. Dr. Ko is interested in the NMJ as a model synapse to better understand synaptic structure, function, formation, repair, and maintenance, as well as synapse-glia interactions. His current research focuses on the cellular and molecular mechanisms of the pathogenesis of spinal muscular atrophy (SMA), particularly the possible contribution of motor circuit defects to the pathogenesis of SMA, as well as the role of different cell types in SMA disease mechanisms and potential therapy. In addition, his lab pursues translational research by testing molecules that could potentially be used to treat SMA. Dr. Ko collaborates with many SMA researchers, both in academia and industry, with the hope to develop a novel concept of SMA disease mechanisms and potential therapy for this devastating disease.

Most helpful customer reviews

See all customer reviews...

Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press PDF
Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press EPub
Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press Doc
Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press iBooks
Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press rtf
Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press Mobipocket
Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press Kindle

Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press PDF

Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press PDF

Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press PDF
Spinal Muscular Atrophy: Disease Mechanisms and TherapyFrom Academic Press PDF

Tidak ada komentar:

Posting Komentar